Laura Dumitrescu
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
Dumitrescu, Laura; Papathanasiou, Athanasios; Coclitu, Catalina; Garjani, Afagh; Evangelou, Nikos; Constantinescu, Cris S.; Popescu, Bogdan Ovidiu; Tanasescu, Radu
Authors
Athanasios Papathanasiou
Catalina Coclitu
Afagh Garjani
Dr NIKOS EVANGELOU Nikos.Evangelou@nottingham.ac.uk
CLINICAL PROFESSOR
Cris S. Constantinescu
Bogdan Ovidiu Popescu
Radu Tanasescu
Abstract
Multiple sclerosis (MS) is an immune-mediated disorder of the CNS manifested by recurrent attacks of neurological symptoms (related to focal inflammation) and gradual disability accrual (related to progressive neurodegeneration and neuroinflammation). Sphingosine-1-phosphate-receptor (S1PR) modulators are a class of oral disease-modifying therapies (DMTs) for relapsing MS. The first S1PR modulator developed and approved for MS was fingolimod, followed by siponimod, ozanimod, and ponesimod. All are S1P analogues with different S1PR-subtype selectivity. They restrain the S1P-dependent lymphocyte egress from lymph nodes by binding the lymphocytic S1P-subtype-1-receptor. Depending on their pharmacodynamics and pharmacokinetics, they can also interfere with other biological functions.
Citation
Dumitrescu, L., Papathanasiou, A., Coclitu, C., Garjani, A., Evangelou, N., Constantinescu, C. S., Popescu, B. O., & Tanasescu, R. (2023). An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis. Expert Opinion on Pharmacotherapy, 24(4), 495-509. https://doi.org/10.1080/14656566.2023.2178898
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 7, 2023 |
Online Publication Date | Mar 22, 2023 |
Publication Date | Mar 22, 2023 |
Deposit Date | Mar 29, 2023 |
Publicly Available Date | Mar 29, 2023 |
Journal | Expert Opinion on Pharmacotherapy |
Print ISSN | 1465-6566 |
Electronic ISSN | 1744-7666 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 24 |
Issue | 4 |
Pages | 495-509 |
DOI | https://doi.org/10.1080/14656566.2023.2178898 |
Keywords | Pharmacology (medical); Pharmacology; General Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/19002013 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/14656566.2023.2178898 |
Files
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
(873 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search